<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="3127">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01849601</url>
  </required_header>
  <id_info>
    <org_study_id>acotec-01</org_study_id>
    <nct_id>NCT01849601</nct_id>
  </id_info>
  <brief_title>Effectiveness and Safety Study of Peripheral Balloon Dilatation Catheter in Percutaneous Transluminal Angioplasty(PTA) Procedure</brief_title>
  <official_title>A Prospective, Multicenter and Single-arm Target Value Clinical Study on the Efficacy and Safety of Peripheral Balloon Dilatation Catheter in PTA Procedure</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Acotec Scientific Co., Ltd</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Acotec Scientific Co., Ltd</source>
  <oversight_info>
    <authority>China: Food and Drug Administration</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether the peripheral balloon dilatation catheter
      (trade name: Iris) is safe an effective in PTA procedure.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>December 2012</start_date>
  <completion_date type="Anticipated">October 2013</completion_date>
  <primary_completion_date type="Anticipated">July 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>technical success rate of PTA procedure</measure>
    <time_frame>instant</time_frame>
    <safety_issue>No</safety_issue>
    <description>successfully pass lesion(s)
successfully dilate lesion(s)( diameter of balloon reach at least 90% of the nominal diameter)
successfully retrieve
The definition of technical success rate of PTA procedure is that, all of the above 3 point are successful</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>safety assessment</measure>
    <time_frame>day 2 to day 10 after procedure or hospital discharge</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>relevant balloon complications occurred during procedure(failure of balloon inflation, rupture of the balloon, failure of balloon deflation, failure of withdrawn, catheter fracture, etc.).
Relevant major vascular complications occurred during procedure (rupture of blood vessels and acute vascular occlusion caused by dilation).</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">167</enrollment>
  <condition>Peripheral Arterial Disease</condition>
  <arm_group>
    <arm_group_label>PTA catheter (Iris)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>percutaneous transluminal angioplasty balloon catheter</intervention_name>
    <arm_group_label>PTA catheter (Iris)</arm_group_label>
    <other_name>PTA catheter</other_name>
    <other_name>trade name: Iris</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age: 18 yrs - 80 yrs.

          -  patients with iliac and / or femoral artery atherosclerotic lesions

          -  Rutherford grade of 1-5;

          -  Target lesion stenosisâ‰¥70% (visual estimation) (proportion of Trans-Atlantic
             Inter-Society Consensus(TASC) B, C and D grade lesions not less than 60% )

          -  Patients being able to understand the purpose of the test, and being volunteered to
             participate in and sign the informed consent.

        Exclusion Criteria:

          -  Patients not suitable for receiving interventional surgeries of lower limb arteries
             for treatment;

          -  Patients require intervention of lesions besides unilateral iliac and femoral artery
             lesions at the same time;

          -  Patients have been involved in clinical trials of other drugs or medical devices
             within the past three months;

          -  Patient is unable or unwilling to participate in this trial;

          -  Patients with serious heart and brain, liver and other vital organs failure;

          -  Patients with life expectancy less than 6 months;

          -  Pregnant women.
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>wei guo, Dr</last_name>
    <email>pla301dml@vip.sina.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Wei Guo</name>
      <address>
        <city>Beijing</city>
        <zip>100853</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Wei Guo, Dr</last_name>
      <email>pla301dml@vip.sina.com</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>November 2012</verification_date>
  <lastchanged_date>May 7, 2013</lastchanged_date>
  <firstreceived_date>April 28, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Peripheral Arterial Disease</mesh_term>
    <mesh_term>Peripheral Vascular Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
